Publication:
First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment

dc.contributor.buuauthorSarandöl, Aslı
dc.contributor.buuauthorSarandöl, Emre
dc.contributor.buuauthorAçıkgöz, Hacer Ebru
dc.contributor.buuauthorEker, Salih Saygın
dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorDirican, Melahat
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPsikiyatri Ana Bilim Dalı
dc.contributor.departmentKlinik Biyokimya Ana Bilim Dalı
dc.contributor.orcid0000-0002-2593-7196
dc.contributor.researcheridABE-1716-2020
dc.contributor.researcheridQ-9477-2019
dc.contributor.scopusid14020405100
dc.contributor.scopusid55943324800
dc.contributor.scopusid56800707200
dc.contributor.scopusid14019347700
dc.contributor.scopusid14061855100
dc.contributor.scopusid6601919847
dc.date.accessioned2022-06-13T08:07:55Z
dc.date.available2022-06-13T08:07:55Z
dc.date.issued2015-11
dc.description.abstractAimsIn the present study, our aim was to investigate the oxidative-antioxidative systems in unmedicated first-episode psychosis (FEP) patients at the beginning and after short-term treatment. MethodsThis study consisted of 29 patients who experienced an FEP and 25 control subjects. In order to investigate the oxidative status, we determined plasma malondialdehyde (MDA) levels, oxidizability of red blood cells, oxidation and oxidizability of apolipoprotein B-containing lipoproteins (apo B-basal MDA and apo B-MDA). In order to evaluate the antioxidative defense, we measured serum total antioxidative capacity, uric acid, albumin, total bilirubin and vitamin E levels and serum paraoxonase/arylesterase, whole blood glutathione peroxidase (GPx) and red blood cell superoxide dismutase activities before and after 6 weeks of treatment in patients with FEP. ResultsPlasma MDA and apo B-basal MDA levels and red blood cell superoxide dismutase activity were significantly higher and serum arylesterase and whole blood-GPx activities were lower in the FEP group than those of the healthy control group. There were not any significant changes in the oxidative and antioxidative system parameters (except increased vitamin E levels) after treatment. ConclusionsThe results of this study suggest that FEP is accompanied by oxidative stress. However, further studies are needed to clarify the role of oxidative stress in the physiopathologic mechanisms of FEP, so that oxidative and antioxidative system parameters can be used in the management of these patients. In accordance with psychiatric evaluation, for a better management, patients with FEP may require a multidisciplinary approach, including oxidative and antioxidative system parameters.
dc.identifier.citationSarandöl, A. vd. (2015). "First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment". Psychiatry and Clinical Neurosciences, 69(11), 699-707.
dc.identifier.endpage707
dc.identifier.issn1323-1316
dc.identifier.issue11
dc.identifier.pubmed26172069
dc.identifier.scopus2-s2.0-84945458763
dc.identifier.startpage699
dc.identifier.urihttps://doi.org/10.1111/pcn.12333
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/10.1111/pcn.12333
dc.identifier.urihttp://hdl.handle.net/11452/27089
dc.identifier.volume69
dc.identifier.wos000363891900005
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherWiley
dc.relation.journalPsychiatry and Clinical Neurosciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAffective disorders
dc.subjectAntioxidant
dc.subjectFirst-episode psychosis
dc.subjectOxidative stress
dc.subjectSchizophrenia
dc.subjectLow-density-lipoprotein
dc.subjectDrug-naive patients
dc.subjectAntioxidant defense
dc.subjectLipid peroxide
dc.subjectSschizophrenia
dc.subjectPlasma
dc.subjectOnset
dc.subjectSusceptibility
dc.subjectDisease
dc.subjectNeurosciences & neurology
dc.subjectPsychiatry
dc.subject.emtreeAlbumin
dc.subject.emtreeAlpha tocopherol
dc.subject.emtreeApolipoprotein B
dc.subject.emtreeAryldialkylphosphatase
dc.subject.emtreeArylesterase
dc.subject.emtreeBilirubin
dc.subject.emtreeGlutathione peroxidase
dc.subject.emtreeMalonaldehyde
dc.subject.emtreeNeuroleptic agent
dc.subject.emtreeSuperoxide dismutase
dc.subject.emtreeUric acid
dc.subject.emtreeALB protein, human
dc.subject.emtreeAlpha tocopherol
dc.subject.emtreeAPOB protein, human
dc.subject.emtreeApolipoprotein B100
dc.subject.emtreeAryldialkylphosphatase
dc.subject.emtreeArylesterase
dc.subject.emtreeBilirubin
dc.subject.emtreeCarboxylesterase
dc.subject.emtreeGlutathione peroxidase
dc.subject.emtreeMalonaldehyde
dc.subject.emtreeNeuroleptic agent
dc.subject.emtreeSerum albumin
dc.subject.emtreeSuperoxide dismutase
dc.subject.emtreeUric acid
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeClinical article
dc.subject.emtreeClinical evaluation
dc.subject.emtreeControlled study
dc.subject.emtreeEnzyme activity
dc.subject.emtreeEnzyme blood level
dc.subject.emtreeErythrocyte
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeMale
dc.subject.emtreeOxidation
dc.subject.emtreeOxidative stress
dc.subject.emtreePathophysiology
dc.subject.emtreePatient care
dc.subject.emtreeProtein blood level
dc.subject.emtreePsychosis
dc.subject.emtreeShort course therapy
dc.subject.emtreeVitamin blood level
dc.subject.emtreeBlood
dc.subject.emtreeCase control study
dc.subject.emtreeDrug effects
dc.subject.emtreeMetabolism
dc.subject.emtreeOxidation reduction reaction
dc.subject.emtreeOxidative stress
dc.subject.emtreePsychotic disorders
dc.subject.emtreeYoung adult
dc.subject.meshAdult
dc.subject.meshAntipsychotic agents
dc.subject.meshApolipoprotein B-100
dc.subject.meshAryldialkylphosphatase
dc.subject.meshBilirubin
dc.subject.meshCarboxylic ester hydrolases
dc.subject.meshCase-control studies
dc.subject.meshErythrocytes
dc.subject.meshFemale
dc.subject.meshGlutathione peroxidase
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMalondialdehyde
dc.subject.meshOxidation-reduction
dc.subject.meshOxidative stress
dc.subject.meshPsychotic disorders
dc.subject.meshSerum albumin
dc.subject.meshSuperoxide dismutase
dc.subject.meshUric acid
dc.subject.meshVitamin E
dc.subject.meshYoung adult
dc.subject.scopusOxidative Stress; Acetylcysteine; Bipolar Disorder
dc.subject.wosClinical neurology
dc.subject.wosNeurosciences
dc.subject.wosPsychiatry
dc.titleFirst-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Psikiyatri Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Klinik Biyokimya Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: